AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 55 filers reported holding AVROBIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $114,000 | -62.5% | 177,333 | -46.3% | 0.02% | -67.4% |
| Q2 2022 | $304,000 | -32.0% | 330,281 | -2.4% | 0.05% | -23.3% |
| Q1 2022 | $447,000 | -46.8% | 338,422 | +55.1% | 0.06% | -43.4% |
| Q4 2021 | $840,000 | -20.2% | 218,137 | +15.6% | 0.11% | -0.9% |
| Q3 2021 | $1,053,000 | +70.7% | 188,768 | +172.1% | 0.11% | +55.1% |
| Q2 2021 | $617,000 | +36.5% | 69,386 | +94.7% | 0.07% | -8.0% |
| Q1 2021 | $452,000 | +52.7% | 35,645 | +67.7% | 0.08% | +56.2% |
| Q4 2020 | $296,000 | – | 21,256 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |